Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
2000
Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes
2010
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
1999
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Telomerase as a therapeutic target for malignant gliomas
2002
A phase I surrogate endpoint study of SU6668 in patients with solid tumors
2004
Inflammation and cancer
2002 StandoutNature
Post-translational Proteolytic Processing of Procollagen C-terminal Proteinase Enhancer Releases a Metalloproteinase Inhibitor
2000
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe
2005
How Tumors Become Angiogenic
1996
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
2004
Wound repair and regeneration
2008 StandoutNature
Tissue inhibitors of metalloproteinases: evolution, structure and function
2000 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts
1990
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Development and Disease in Proteinase-Deficient Mice
1998
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
The circadian clock: pacemaker and tumour suppressor
2003
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
1999
Localized Surface Plasmon Resonance Spectroscopy of Single Silver Nanocubes
2005
Complex role of matrix metalloproteinases in angiogenesis
1998
Mitochondrion-mediated apoptosis in HIV-1 infection
2003
Immunity, Inflammation, and Cancer
2010 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
2014
The Roles of Claudin Superfamily Proteins in Paracellular Transport
2001
Timp-1 Is Important for Epithelial Proliferation and Branching Morphogenesis during Mouse Mammary Development
1999
Shell-isolated nanoparticle-enhanced Raman spectroscopy
2010 StandoutNature
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Telomerase: A target for cancer therapeutics
2002
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
2003
Cancer vaccines and carbohydrate epitopes
2011
Expression of activated gelatinase in human invasive breast carcinoma
1993
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
2009
2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)
1998
AdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in Mice
2001
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
2011
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Growth factor–induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen
2001
The Pathophysiology of Mitochondrial Cell Death
2004 StandoutScience
Zymographic Techniques for the Analysis of Matrix Metalloproteinases and their Inhibitors
2005
TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?
2000
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.
1998
Intravitreal Injection of Erythropoietin Protects both Retinal Vascular and Neuronal Cells in Early Diabetes
2008
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
1993
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Photovoltage Mechanism for Room Light Conversion of Citrate Stabilized Silver Nanocrystal Seeds to Large Nanoprisms
2008 StandoutNobel
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
1999
Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation
2000
Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
2000
Targeted Delivery of a Sialic Acid-Blocking Glycomimetic to Cancer Cells Inhibits Metastatic Spread
2015
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
VEGF Receptor Signal Transduction
2001
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
1998
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
1996
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Laser-Induced Growth of Monodisperse Silver Nanoparticles with Tunable Surface Plasmon Resonance Properties and a Wavelength Self-Limiting Effect
2007
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Bioavailable copper modulates oxidative phosphorylation and growth of tumors
2013
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor
2005
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Angiogenesis in Endocrine Tumors
2003
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.
2000
Creatine and Creatinine Metabolism
2000 Standout
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
2000
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation
2020
Works of Daniel E. Gómez being referenced
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
2004
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
2009
Deregulation of the signaling pathways controlling urokinase production
1999
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
2010
Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin
2011
The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells
2001
Liver tumors and possible preneoplastic lesions, induced by a food‐derived heterocyclic amine in cynomolgus monkeys; a study of histology and cytokeratin expression
1996
Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1show vascular endothelial growth factor expression
1998
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
2012
Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotype
1988
Chronic In Vitro Exposure to 3′-Azido-2′, 3′-Dideoxythymidine Induces Senescence and Apoptosis and Reduces Tumorigenicity of Metastatic Mouse Mammary Tumor Cells
2001
Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) Treatment
1998
Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.
1996
Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis.
1997
Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties.
1996
Cancer vaccines: An update with special focus on ganglioside antigens (Review)
2002
Dietary heterocyclic amines as potential human carcinogens: experimental data from nonhuman primates.
1997
The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review).
1999
Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides.
2013
Mammary carcinoma cells over‐expressing tissue inhibitor of metalloproteinases‐1show vascular endothelial growth factor expression
1998
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
1997
A Simple Route to Tunable Two‐Dimensional Arrays of Quantum Dots
2005
Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer
2006